Table 1

Cardiovascular risk factors


Control individuals (n = 87)
Corticosteroids (-)
Corticosteroids (+)





Active BD (n = 20)
Stable or inactive BD (n = 33)
Active BD (n = 19)
Stable or inactive BD (n = 15)

Males/females (n)
58/32
13/7
22/11
14/5
9/6
Age (years)
40.1 ± 1.2
40.9 ± 2.5
40.6 ± 1.5
38.4 ± 2.5
37.6 ± 2.9
Hypertension (n [%])
13 (14.9)
2 (10.1)
3 (9.4)
5 (26.3)
3 (20.0)
Smokers (n [%])
40 (46)
12 (60.0)
18 (54.4)
13 (68.4)
5 (33.3)
BMI (kg/m2)
27.2 ± 0.7
23.5 ± 1.3
25.2 ± 0.6
24.7 ± 1.0
23.4 ± 1.1
Total cholesterol (mg/dl)
193.2 ± 5.3
200.7 ± 16.0
202.7 ± 8.3
209.6 ± 14.1
215.4 ± 12.2
LDL-cholesterol (mg/dl)
132.4 ± 4.5
120.1 ± 15.1
132.2 ± 7.8
134.6 ± 4.9
143.5 ± 11.2
HDL-cholesterol (mg/dl)
47.7 ± 1.4
44.7 ± 5.5
46.8 ± 2.5
52.1 ± 4.5
52.4 ± 4.1
Triglycerides (mg/dl)
106.6 ± 9.9
115.5 ± 32.2
124.1 ± 12.5
133.2 ± 25.3
125.4 ± 22.8
Glucose (mg/dl)
85.3 ± 1.5
94.1 ± 4.4
91.3 ± 2.0
89.9 ± 3.7
84.5 ± 3.5

Shown are cardiovascular risk factors in control individuals and in patients with Behçet's disease (BD) divided according to the receipt (+) or nonreceipt (-) of corticosteroid treatment and the clinical disease status. Unless otherwise stated, values are expressed as mean ± standard error. BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

Protogerou et al. Arthritis Research & Therapy 2007 9:R90   doi:10.1186/ar2289

Open Data